Gubler Marie-Claire, Heidet Laurence, Antignac Corinne
Inserm U-574, hôpital Necker-Enfants-malades, 149, rue de Sèvres, 75743 Paris cedex 15, France.
Nephrol Ther. 2007 Jun;3(3):113-20. doi: 10.1016/j.nephro.2007.03.005. Epub 2007 May 8.
Alport syndrome is an inherited disorder characterized by progressive hematuric nephritis with structural defects of the glomerular basement membrane, and sensorineural deafness. Ocular abnormalities are frequently associated. The incidence is approximatively 1/5000. The renal disease is severe in male patients and should be responsible for 2% of end-stage renal failure. Alport syndrome is heterogeneous at the clinical and genetic levels. It occurs as a consequence of structural abnormalities in type IV collagen, the major constituent of basement membranes. Six genetically distinct chains of type IV collagen have been identified. Mutations in the COL4A5 gene located at Xq22, and encoding the alpha 5(IV) chain are responsible for X-linked Alport syndrome whereas COL4A3 or COL4A4 located "head to head" on chromosome 2 are involved in the rarer autosomal forms of the disease.
阿尔波特综合征是一种遗传性疾病,其特征为进行性血尿性肾炎伴肾小球基底膜结构缺陷以及感音神经性耳聋。眼部异常也常与之相关。发病率约为1/5000。男性患者的肾脏疾病较为严重,占终末期肾衰竭病例的2%。阿尔波特综合征在临床和基因水平上具有异质性。它是由于基底膜的主要成分IV型胶原结构异常所致。已鉴定出IV型胶原的六条基因不同的链。位于Xq22的COL4A5基因发生突变并编码α5(IV)链,导致X连锁型阿尔波特综合征,而位于2号染色体上“头对头”排列的COL4A3或COL4A4基因则与该疾病较罕见的常染色体形式有关。